1. Home
  2. XERS vs NOVA Comparison

XERS vs NOVA Comparison

Compare XERS & NOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • NOVA
  • Stock Information
  • Founded
  • XERS 2005
  • NOVA 2012
  • Country
  • XERS United States
  • NOVA United States
  • Employees
  • XERS N/A
  • NOVA N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • NOVA Power Generation
  • Sector
  • XERS Health Care
  • NOVA Utilities
  • Exchange
  • XERS Nasdaq
  • NOVA Nasdaq
  • Market Cap
  • XERS 500.2M
  • NOVA 462.3M
  • IPO Year
  • XERS 2018
  • NOVA 2019
  • Fundamental
  • Price
  • XERS $3.47
  • NOVA $3.77
  • Analyst Decision
  • XERS Buy
  • NOVA Buy
  • Analyst Count
  • XERS 3
  • NOVA 22
  • Target Price
  • XERS $4.87
  • NOVA $10.62
  • AVG Volume (30 Days)
  • XERS 1.8M
  • NOVA 9.0M
  • Earning Date
  • XERS 11-08-2024
  • NOVA 02-19-2025
  • Dividend Yield
  • XERS N/A
  • NOVA N/A
  • EPS Growth
  • XERS N/A
  • NOVA N/A
  • EPS
  • XERS N/A
  • NOVA N/A
  • Revenue
  • XERS $187,361,000.00
  • NOVA $809,977,000.00
  • Revenue This Year
  • XERS $24.27
  • NOVA $20.14
  • Revenue Next Year
  • XERS $18.57
  • NOVA $24.63
  • P/E Ratio
  • XERS N/A
  • NOVA N/A
  • Revenue Growth
  • XERS 22.72
  • NOVA 12.18
  • 52 Week Low
  • XERS $1.69
  • NOVA $2.99
  • 52 Week High
  • XERS $3.87
  • NOVA $16.36
  • Technical
  • Relative Strength Index (RSI)
  • XERS 54.75
  • NOVA 40.45
  • Support Level
  • XERS $3.32
  • NOVA $3.28
  • Resistance Level
  • XERS $3.57
  • NOVA $3.85
  • Average True Range (ATR)
  • XERS 0.18
  • NOVA 0.43
  • MACD
  • XERS -0.01
  • NOVA -0.03
  • Stochastic Oscillator
  • XERS 42.86
  • NOVA 30.62

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.

About NOVA Sunnova Energy International Inc.

Sunnova Energy International Inc is a residential solar and energy storage service provider company. It offers services such as operations and maintenance, monitoring, repairs and replacements, equipment upgrades, and onsite power optimization. The products and services offered by the group include Add-on battery storage, Home solar protection plans, New solar battery storage, and various other solar systems. It operates in a single reportable segment: solar energy products and services.

Share on Social Networks: